<p><em>Expert Perspectives</em>^® delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. <em>Expert Perspectives</em>^®<em> in PSMA+ mCRPC </em>will feature community-selected experts and topics that we hope you will find of value in your clinical practice.</p> <div class="bodytext_module_container"> <div class="bodytext_module_body"> <hr /> <p><strong>VIEW THE TOPICS:</strong></p> <p><br></p> </div> </div> <div class="bodytext_module_container"> <div class="bodytext_module_body"> <p><span style="color: #2f6a81;"><strong>Patient Care Perspectives</strong></span></p> <ul> <li>Balancing Precision in Patient Selection with Equitable Access to Therapy</li> <li>Impacts from Exercise and Nutrition in Patients With Prostate Cancer</li> <li>Maturing Role of PSMA PET in Prognosis, Treatment Selection and Response Assessment</li> <li>Metastatic Prostate Cancer On the Rise: Epidemiology Explored</li> <li>Opening Up Unexplored Avenues to Treat Lethal Prostate Cancer</li> <li>Optimizing Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer</li> </ul> <p><br></p> <p><strong><span style="color: #2f6a81;">Clinical Topic Updates</span></strong></p> <ul> <li>Improving Prostate Cancer Screening Strategies to Reduce the Pool of Metastatic Disease</li> <li>Integrating Recent mCRPC FDA Approvals Into Clinical Practice</li> <li>Metabolic Health and Cardiovascular Risk in Patients With Prostate Cancer</li> <li>On-Treatment Biomarkers During PSMA-targeted Radioligand Therapy</li> <li>PARPi Benefit in Patients with Metastatic Castration-Resistant Prostate Cancer</li> <li>Second Taxane for Progression After Triplet Therapy: Treatment Considerations</li> </ul> <p><br></p> <p><strong><span style="color: #2f6a81;">Expert Roundtables</span></strong></p> <ul> <li>Barriers to Progress and Opportunities for Innovation in Prostate Cancer Care</li> <li>Expert Roundtable Podcast: Redefining Precision Cancer Care: From -Omics to AI-Driven Biomarkers</li> <li>Integrating AI Across the Prostate Cancer Disease Continuum: Progress and Pitfall</li> </ul> </div> </div>